Cargando…
Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment
Angiosarcoma is the most common malignant cardiac tumor. Cardiac angiosarcoma is a highly lethal neoplasm that is largely resistant to conventional anti-cancer therapy. Mean survival of patients with cardiac angiosarcoma is only 4 months, and almost all patients will succumb to the disease within 1...
Autores principales: | Galván, Dana C., Ayyappan, Anoop P., Bryan, Brad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231448/ https://www.ncbi.nlm.nih.gov/pubmed/30460329 http://dx.doi.org/10.18632/oncoscience.472 |
Ejemplares similares
-
Correction: Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment
por: Galván, Dana C., et al.
Publicado: (2019) -
Propranolol and Weekly Paclitaxel in the Treatment of Metastatic Heart Angiosarcoma
por: Fiste, Oraianthi, et al.
Publicado: (2020) -
Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
por: Daguzé, Justine, et al.
Publicado: (2016) -
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma
por: Banavali, Shripad, et al.
Publicado: (2015) -
Primary Cardiac Angiosarcoma
por: Kodali, Dhatri, et al.
Publicado: (2006)